Skip to main content
. 2019 Nov 26;18(2):352–363. doi: 10.1111/jth.14665

Table 5.

Number of patients experiencing any adverse event or serious adverse event (FAS analysis; N = 45)

 

HFC

(N = 22)

Cryoprecipitate

(N = 23)

AE, n 225 228
Patients with AE, n (%) 22 (100) 23 (100)
Severity of AE, n
Mild 222 214
Moderate 2 12
Severe 1 2
Probably or possibly related AE, n 0 0
SAE, n 6 17

Abbreviations: AE, adverse event; FAS, full analysis set; HFC, human fibrinogen concentrate; SAE, serious adverse event.